.Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J05A_DirectActingAntivirals.J05AR01_ZidovudineAndLamivudine.ZidovudineAndLamivudine .Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J05A_DirectActingAntivirals.J05AR01_ZidovudineAndLamivudine.ZidovudineAndLamivudine| name: | ZidovudineAndLamivudine |
| ATC code: | J05AR01 | route: | oral |
| n-compartments | 1 |
Zidovudine and lamivudine are antiretroviral medications combined to treat HIV-1 infection. Both are nucleoside reverse transcriptase inhibitors (NRTIs) and are used as a backbone in combination antiretroviral therapy (ART). The fixed-dose combination is approved and widely used today for the management of HIV infection.
Pharmacokinetic parameters for zidovudine and lamivudine following oral administration in healthy adult volunteers.
Zhou, XJ, et al., & Sommadossi, JP (2000). Plasma population pharmacokinetics and penetration into cerebrospinal fluid of indinavir in combination with zidovudine and lamivudine in HIV-1-infected patients. AIDS (London, England) 14(18) 2869–2876. DOI:10.1097/00002030-200012220-00008 PUBMED:https://pubmed.ncbi.nlm.nih.gov/11153668
Anderson, PL, et al., & Fletcher, CV (2006). Pharmacogenetic characteristics of indinavir, zidovudine, and lamivudine therapy in HIV-infected adults: a pilot study. Journal of acquired immune deficiency syndromes (1999) 42(4) 441–449. DOI:10.1097/01.qai.0000225013.53568.69 PUBMED:https://pubmed.ncbi.nlm.nih.gov/16791115
Bhana, N, et al., & Figgitt, DP (2002). Zidovudine: a review of its use in the management of vertically-acquired pediatric HIV infection. Paediatric drugs 4(8) 515–553. DOI:10.2165/00128072-200204080-00004 PUBMED:https://pubmed.ncbi.nlm.nih.gov/12126455